GlassScriptPhysician profile
Jeffrey Brimmer
NPI 1295153450
$9,877.32
in general payments reported to CMS, 2019-2025
46 companies · $897 in 2025
The $897 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,591 · 2020: $1,144 · 2021: $207 · 2022: $132 · 2023: $526 · 2024: $381 · 2025: $897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,803.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,617.50 | 2019-2025 | 7 X 23mm Citrelock Implant, Prophecy |
| Arthrex, INC. | $1,748.84 | 2019 | |
| Wright Medical Technology, INC. | $1,114.46 | 2019-2020 | |
| Team 1, LLC | $1,073.37 | 2019 | |
| Horizon Therapeutics Plc | $644.52 | 2019-2023 | Krystexxa |
| Acera Surgical, INC. | $522.30 | 2023-2025 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $451.99 | 2019-2025 | Grafix Pl, Stravix, Oasis |
| Paragon 28, INC. | $148.54 | 2023 | Additive Orthopedics |
| Crossroads Extremity Systems, LLC | $125.93 | 2019 | |
| Flower Orthopedics Coporation | $110.66 | 2019 | |
| Voom Medical Devices, INC. | $102.77 | 2025 | Revcon Instrument Kit, Sterile |
| Integra Lifesciences Corporation | $101.51 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medtronic, INC. | $72.34 | 2022-2024 | Intellis Adaptivestim |
| Bioventus LLC | $63.95 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Angiodynamics, INC. | $62.49 | 2019-2022 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $58.24 | 2019 | |
| Access Pro Medical, LLC | $57.69 | 2023 | Matriderm |
| Kerecis Limited | $56.96 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Sebela Pharmaceuticals INC. | $56.72 | 2020 | |
| Treace Medical Concepts, INC. | $53.78 | 2023-2024 | |
| Organogenesis INC. | $51.86 | 2020-2023 | Puraply |
| Zimvie INC. | $47.59 | 2022-2023 | |
| Amgen INC. | $44.39 | 2024-2025 | Krystexxa |
| Zyla Life Sciences, INC. | $40.88 | 2019 | |
| Progenacare Global, LLC | $39.46 | 2023-2024 | |
| Depuy Synthes Sales INC. | $33.06 | 2021 | |
| Paratek Pharmaceuticals, INC. | $29.96 | 2023-2025 | Nuzyra |
| Next Science LLC | $28.95 | 2024 | Blastx, Xperience, Surgx |
| Osiris Therapeutics INC. | $24.09 | 2019 | |
| Misonix INC | $23.75 | 2020 | |
| Djo, LLC | $23.45 | 2021 | |
| Nabriva Therapeutics, Plc | $22.46 | 2022 | |
| Sanara Medtech INC. | $21.36 | 2023 | Celleraterx |
| Pacira Pharmaceuticals Incorporated | $21.29 | 2019 | |
| Convatec INC. | $18.20 | 2023 | |
| Triad Life Sciences INC. | $17.60 | 2021 | |
| Merck Sharp & Dohme LLC | $16.05 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.91 | 2025 | Jublia |
| Embody, INC. | $15.75 | 2021 | |
| Abbott Laboratories | $15.00 | 2023 | Proclaim |
| Acell, INC. | $14.69 | 2019 | |
| Kci USA, INC. | $14.67 | 2020 | |
| Averitas Pharma INC. | $14.46 | 2023 | Qutenza |
| Reprise Biomedical, INC. | $13.08 | 2022 | |
| Orthofix Medical, INC. | $12.47 | 2025 | Physio-Stim |
| Abbvie INC. | $12.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Brimmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.